Showing results (2621-2630 of 2,674) with videos related to

Sort By:
Pageof 268
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 25, 2023
Flexible Organic Photovoltaic-Powered Hydrogel Bioelectronic Dressing With Biomimetic Electrical Stimulation for Healing Infected Diabetic WoundsYi-Wei Hu, Yu-Heng Wang, Fang Yang, et al.
Gastroenterology|November 13, 2019
Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal CancerTej D Azad, Aadel A Chaudhuri, Penny Fang, et al.
Nature Communications|July 16, 2024
Aging aggravates aortic aneurysm and dissection via miR-1204-MYLK signaling axis in miceZe-Long Liu, Yan Li, Yi-Jun Lin, et al.
Nature Immunology|December 7, 2010
Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signalingDan Levy, Alex J Kuo, Yanqi Chang, et al.
Therapeutic Advances in Medical Oncology|July 21, 2022
Efficacy of local therapy to metastatic foci in nasopharyngeal carcinoma: large-cohort strictly-matched retrospective studyMeng-Xia Zhang, Ting Liu, Rui You, et al.
European Radiology|March 1, 2022
Comparison between spleen and liver stiffness measurements by sound touch elastography for diagnosing cirrhosis at different aminotransferase levels: a prospective multicenter studyWei Zhang, Jinfen Wang, Runze Linghu, et al.
Brain Research Bulletin|July 16, 2025
Alterations in whole-brain white matter fiber networks in individuals with autism spectrum disorder after social skills trainingGang-Qiang Han, Siu-Ching Kat, Hui Wang, et al.
Nature Genetics|March 16, 2024
Genome assemblies of 11 bamboo species highlight diversification induced by dynamic subgenome dominancePeng-Fei Ma, Yun-Long Liu, Cen Guo, et al.
Cancer Research|December 22, 2011
Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escapeSeng-Ryong Woo, Meghan E Turnis, Monica V Goldberg, et al.
Cell Reports. Medicine|October 16, 2024
A phase 2 trial of gemcitabine plus toripalimab for cisplatin-ineligible patients with recurrent or metastatic nasopharyngeal carcinomaXiong Zou, Xi Ding, Zheng-Kai Feng, et al.
Pageof 268